News and Events

Sponsor This Page

Contact us to fund this vital program


July 12, 2011

Using Nanotechnology to Develop New Ion Channel Drugs for Epilepsy

The University of Southampton has announced that Dr. Maurits de Planque of the university's Nano Research Group is using nanotechnology to develop faster and less expensive methods of testing pharmaceutical drugs to treat diseases such as epilepsy... Learn More

July 12, 2011

Researchers Track Effects of Febrile Seizures on Epilepsy

As our understanding of genetics improves and the range of available experimental, clinical and neuroimaging examination techniques increase, researchers are better able to study the relationship between febrile convulsions and epilepsy. In a rese... Learn More

July 05, 2011

Rufinamide Evaluated for Treating Dravet Syndrome

The use of the anticonvuslant drug rufinamide (1-[(2,6-difluorophenil1) methyl1]-1 hydro 1,2,3-triazole-4 carboxamide) in the adjunctive treatment of Lennox-Gastaut syndrome (LGS) is well known. However, in the July 2011 issue of Neuropsychiat... Learn More

July 05, 2011

Use of Verapamil to Treat Dravet Syndrome Suggests Future Therapies

Dr. Paola Iannettia of the Division of Pediatric Neurology, Department of Paediatrics, University of Rome "La Sapienza," et al., report in the journal Epilepsy Research ("Addition of verapamil in the treatment of s... Learn More

July 05, 2011

Adult Study Finds Link Between Dravet Syndrome, Epileptic Encepalopathy

In an article in the journal Brain ("Dravet syndrome as epileptic encephalopathy: evidence from long-term course and neuropathology," June 29, 2011), Claudia B. Catarino of the Department of Clinical and Experimental Epilepsy, U... Learn More

Copyright © Dravet.org 2012
All rights reserved
Disclaimer | Privacy Policy

Dravet.org
PO Box 66599
Baltimore, MD 21239-6599 USA
866-828-1843
LinkedIn
E-mail Signup